{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:06:15Z","timestamp":1786982775674,"version":"build-2736575974"},"reference-count":128,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T00:00:00Z","timestamp":1617840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T00:00:00Z","timestamp":1617840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s40265-021-01502-4","type":"journal-article","created":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T09:03:14Z","timestamp":1617872594000},"page":"749-770","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Pharmacotherapy for Nonconvulsive Seizures and Nonconvulsive Status Epilepticus"],"prefix":"10.1007","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7049-6484","authenticated-orcid":false,"given":"Pablo","family":"Bravo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1709-4440","authenticated-orcid":false,"given":"Aparna","family":"Vaddiparti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6333-832X","authenticated-orcid":false,"given":"Lawrence J.","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,8]]},"reference":[{"issue":"10","key":"1502_CR1","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1111\/epi.13121","volume":"56","author":"E Trinka","year":"2015","unstructured":"Trinka E, Cock H, Hesdorffer D, Rossetti AO, Scheffer IE, Shinnar S, et al. A definition and classification of status epilepticus\u2014report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia. 2015;56(10):1515\u201323.","journal-title":"Epilepsia"},{"issue":"1","key":"1502_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/archneur.1973.00490190019001","volume":"28","author":"BS Meldrum","year":"1973","unstructured":"Meldrum BS, Horton RW. Physiology of status epilepticus in primates. Arch Neurol. 1973;28(1):1\u20139.","journal-title":"Arch Neurol."},{"issue":"1","key":"1502_CR3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1001\/archneur.1973.00490190028002","volume":"28","author":"BS Meldrum","year":"1973","unstructured":"Meldrum BS, Brierley JB. Prolonged epileptic seizures in primates. Ischemic cell change and its relation to ictal physiological events. Arch Neurol. 1973;28(1):10\u20137.","journal-title":"Arch Neurol."},{"issue":"2","key":"1502_CR4","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1001\/archneur.1973.00490260026003","volume":"29","author":"BS Meldrum","year":"1973","unstructured":"Meldrum BS, Vigouroux RA, Brierley JB. Systemic factors and epileptic brain damage. Prolonged seizures in paralyzed, artificially ventilated baboons. Arch Neurol. 1973;29(2):82\u20137.","journal-title":"Arch Neurol."},{"issue":"6","key":"1502_CR5","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1111\/j.1528-1157.1988.tb04226.x","volume":"29","author":"GL Holmes","year":"1988","unstructured":"Holmes GL, Thompson JL, Marchi T, Feldman DS. Behavioral effects of kainic acid administration on the immature brain. Epilepsia. 1988;29(6):721\u201330.","journal-title":"Epilepsia"},{"issue":"4","key":"1502_CR6","first-page":"611","volume":"9","author":"NW Milgram","year":"1988","unstructured":"Milgram NW, Isen DA, Mandel D, Palantzas H, Pepkowski MJ. Deficits in spontaneous behavior and cognitive function following systemic administration of kainic acid. Neurotoxicology. 1988;9(4):611\u201324.","journal-title":"Neurotoxicology"},{"issue":"7","key":"1502_CR7","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1001\/jama.1993.03510070076040","volume":"270","author":"Treatment of Convulsive Status Epilepticus","year":"1993","unstructured":"Treatment of Convulsive Status Epilepticus. Recommendations of the Epilepsy Foundation of America\u2019s Working Group on status epilepticus. JAMA. 1993;270(7):854\u20139.","journal-title":"JAMA"},{"issue":"12","key":"1502_CR8","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1056\/NEJM199809173391202","volume":"339","author":"DM Treiman","year":"1998","unstructured":"Treiman DM, Meyers PD, Walton NY, Collins JF, Colling C, Rowan AJ, et al. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med. 1998;339(12):792\u20138.","journal-title":"N Engl J Med."},{"issue":"2","key":"1502_CR9","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/j.1528-1157.1999.tb02070.x","volume":"40","author":"RJ DeLorenzo","year":"1999","unstructured":"DeLorenzo RJ, Garnett LK, Towne AR, Waterhouse EJ, Boggs JG, Morton L, et al. Comparison of status epilepticus with prolonged seizure episodes lasting from 10 to 29 minutes. Epilepsia. 1999;40(2):164\u20139.","journal-title":"Epilepsia"},{"issue":"5","key":"1502_CR10","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1002\/ana.1018","volume":"49","author":"S Shinnar","year":"2001","unstructured":"Shinnar S, Berg AT, Moshe SL, Shinnar R. How long do new-onset seizures in children last? Ann Neurol. 2001;49(5):659\u201364.","journal-title":"Ann Neurol."},{"issue":"4","key":"1502_CR11","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1212\/WNL.58.4.537","volume":"58","author":"G Logroscino","year":"2002","unstructured":"Logroscino G, Hesdorffer DC, Cascino GD, Annegers JF, Bagiella E, Hauser WA. Long-term mortality after a first episode of status epilepticus. Neurology. 2002;58(4):537\u201341.","journal-title":"Neurology"},{"issue":"2","key":"1502_CR12","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1136\/jnnp.74.2.189","volume":"74","author":"AM Husain","year":"2003","unstructured":"Husain AM, Horn GJ, Jacobson MP. Non-convulsive status epilepticus: usefulness of clinical features in selecting patients for urgent EEG. J Neurol Neurosurg Psychiatry. 2003;74(2):189\u201391.","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"6","key":"1502_CR13","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1097\/01.nrl.0000162954.76053.d2","volume":"11","author":"PW Kaplan","year":"2005","unstructured":"Kaplan PW. The clinical features, diagnosis, and prognosis of nonconvulsive status epilepticus. Neurologist. 2005;11(6):348\u201361.","journal-title":"Neurologist."},{"issue":"4","key":"1502_CR14","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/S1474-4422(07)70074-1","volume":"6","author":"H Meierkord","year":"2007","unstructured":"Meierkord H, Holtkamp M. Non-convulsive status epilepticus in adults: clinical forms and treatment. Lancet Neurol. 2007;6(4):329\u201339.","journal-title":"Lancet Neurol."},{"issue":"6","key":"1502_CR15","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.clinph.2017.01.015","volume":"128","author":"LF Pinto","year":"2017","unstructured":"Pinto LF, Gilmore EJ, Petroff OA, Sivaraju A, Rampal N, Hirsch LJ, et al. Cyclic seizures in critically ill patients: Clinical correlates, DC recordings and outcomes. Clin Neurophysiol. 2017;128(6):1083\u201390.","journal-title":"Clin Neurophysiol."},{"issue":"8","key":"1502_CR16","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1111\/j.1528-1157.1998.tb01177.x","volume":"39","author":"RJ DeLorenzo","year":"1998","unstructured":"DeLorenzo RJ, Waterhouse EJ, Towne AR, Boggs JG, Ko D, DeLorenzo GA, et al. Persistent nonconvulsive status epilepticus after the control of convulsive status epilepticus. Epilepsia. 1998;39(8):833\u201340.","journal-title":"Epilepsia"},{"issue":"4","key":"1502_CR17","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1212\/WNL.46.4.1029","volume":"46","author":"RJ DeLorenzo","year":"1996","unstructured":"DeLorenzo RJ, Hauser WA, Towne AR, Boggs JG, Pellock JM, Penberthy L, et al. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology. 1996;46(4):1029\u201335.","journal-title":"Neurology"},{"issue":"3","key":"1502_CR18","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1212\/WNL.50.3.735","volume":"50","author":"DC Hesdorffer","year":"1998","unstructured":"Hesdorffer DC, Logroscino G, Cascino G, Annegers JF, Hauser WA. Incidence of status epilepticus in Rochester, Minnesota, 1965\u20131984. Neurology. 1998;50(3):735\u201341.","journal-title":"Neurology"},{"issue":"2","key":"1502_CR19","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1212\/WNL.54.2.340","volume":"54","author":"AR Towne","year":"2000","unstructured":"Towne AR, Waterhouse EJ, Boggs JG, Garnett LK, Brown AJ, Smith JR Jr, et al. Prevalence of nonconvulsive status epilepticus in comatose patients. Neurology. 2000;54(2):340\u20135.","journal-title":"Neurology"},{"issue":"8","key":"1502_CR20","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1046\/j.1528-1157.2001.0420081031.x","volume":"42","author":"G Logroscino","year":"2001","unstructured":"Logroscino G, Hesdorffer DC, Cascino G, Annegers JF, Hauser WA. Time trends in incidence, mortality, and case-fatality after first episode of status epilepticus. Epilepsia. 2001;42(8):1031\u20135.","journal-title":"Epilepsia"},{"issue":"Suppl 11","key":"1502_CR21","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/j.1528-1167.2005.00409.x","volume":"46","author":"G Logroscino","year":"2005","unstructured":"Logroscino G, Hesdorffer DC, Cascino G, Hauser WA, Coeytaux A, Galobardes B, et al. Mortality after a first episode of status epilepticus in the United States and Europe. Epilepsia. 2005;46(Suppl 11):46\u20138.","journal-title":"Epilepsia"},{"issue":"3","key":"1502_CR22","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s12028-013-9935-x","volume":"20","author":"BS Dham","year":"2014","unstructured":"Dham BS, Hunter K, Rincon F. The epidemiology of status epilepticus in the United States. Neurocrit Care. 2014;20(3):476\u201383.","journal-title":"Neurocrit Care."},{"issue":"7","key":"1502_CR23","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/nrneurol.2015.104","volume":"11","author":"EJ Gilmore","year":"2015","unstructured":"Gilmore EJ, Hirsch LJ. Epilepsy: Status epilepticus epidemiology\u2013tracking a moving target. Nat Rev Neurol. 2015;11(7):377\u20138.","journal-title":"Nat Rev Neurol."},{"issue":"8","key":"1502_CR24","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1111\/epi.16277","volume":"60","author":"PS Bergin","year":"2019","unstructured":"Bergin PS, Brockington A, Jayabal J, Scott S, Litchfield R, Roberts L, et al. Status epilepticus in Auckland, New Zealand: Incidence, etiology, and outcomes. Epilepsia. 2019;60(8):1552\u201364.","journal-title":"Epilepsia"},{"issue":"1","key":"1502_CR25","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.seizure.2004.06.001","volume":"14","author":"LT Penberthy","year":"2005","unstructured":"Penberthy LT, Towne A, Garnett LK, Perlin JB, DeLorenzo RJ. Estimating the economic burden of status epilepticus to the health care system. Seizure. 2005;14(1):46\u201351.","journal-title":"Seizure."},{"issue":"10","key":"1502_CR26","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.seizure.2013.08.003","volume":"22","author":"A Strzelczyk","year":"2013","unstructured":"Strzelczyk A, Knake S, Oertel WH, Rosenow F, Hamer HM. Inpatient treatment costs of status epilepticus in adults in Germany. Seizure. 2013;22(10):882\u20135.","journal-title":"Seizure."},{"issue":"3","key":"1502_CR27","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0920-1211(94)90062-0","volume":"19","author":"Z Liu","year":"1994","unstructured":"Liu Z, Gatt A, Werner SJ, Mikati MA, Holmes GL. Long-term behavioral deficits following pilocarpine seizures in immature rats. Epilepsy Res. 1994;19(3):191\u2013204.","journal-title":"Epilepsy Res."},{"issue":"2","key":"1502_CR28","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.yebeh.2003.11.032","volume":"5","author":"P Krsek","year":"2004","unstructured":"Krsek P, Mikulecka A, Druga R, Kubova H, Hlinak Z, Suchomelova L, et al. Long-term behavioral and morphological consequences of nonconvulsive status epilepticus in rats. Epilepsy Behav. 2004;5(2):180\u201391.","journal-title":"Epilepsy Behav."},{"issue":"5","key":"1502_CR29","first-page":"545","volume":"39","author":"L Turski","year":"1987","unstructured":"Turski L, Cavalheiro EA, Czuczwar SJ, Turski WA, Kleinrok Z. The seizures induced by pilocarpine: behavioral, electroencephalographic and neuropathological studies in rodents. Pol J Pharmacol Pharm. 1987;39(5):545\u201355.","journal-title":"Pol J Pharmacol Pharm."},{"issue":"6","key":"1502_CR30","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1111\/j.1528-1157.1993.tb02123.x","volume":"34","author":"LE Mello","year":"1993","unstructured":"Mello LE, Cavalheiro EA, Tan AM, Kupfer WR, Pretorius JK, Babb TL, et al. Circuit mechanisms of seizures in the pilocarpine model of chronic epilepsy: cell loss and mossy fiber sprouting. Epilepsia. 1993;34(6):985\u201395.","journal-title":"Epilepsia"},{"issue":"3","key":"1502_CR31","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/ana.410180303","volume":"18","author":"G Nevander","year":"1985","unstructured":"Nevander G, Ingvar M, Auer R, Siesjo BK. Status epilepticus in well-oxygenated rats causes neuronal necrosis. Ann Neurol. 1985;18(3):281\u201390.","journal-title":"Ann Neurol."},{"issue":"1","key":"1502_CR32","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1124\/jpet.104.069146","volume":"311","author":"AJ Williams","year":"2004","unstructured":"Williams AJ, Tortella FC, Lu XM, Moreton JE, Hartings JA. Antiepileptic drug treatment of nonconvulsive seizures induced by experimental focal brain ischemia. J Pharmacol Exp Ther. 2004;311(1):220\u20137.","journal-title":"J Pharmacol Exp Ther."},{"issue":"5","key":"1502_CR33","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1111\/epi.14070","volume":"59","author":"U Avdic","year":"2018","unstructured":"Avdic U, Ahl M, Chugh D, Ali I, Chary K, Sierra A, et al. Nonconvulsive status epilepticus in rats leads to brain pathology. Epilepsia. 2018;59(5):945\u201358.","journal-title":"Epilepsia"},{"issue":"1","key":"1502_CR34","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1001\/archneur.55.1.119","volume":"55","author":"MJ Aminoff","year":"1998","unstructured":"Aminoff MJ. Do nonconvulsive seizures damage the brain?\u2014No. Arch Neurol. 1998;55(1):119\u201320.","journal-title":"Arch Neurol."},{"issue":"1","key":"1502_CR35","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1001\/archneur.55.1.117","volume":"55","author":"GB Young","year":"1998","unstructured":"Young GB, Jordan KG. Do nonconvulsive seizures damage the brain?\u2014Yes. Arch Neurol. 1998;55(1):117\u20139.","journal-title":"Arch Neurol."},{"issue":"1","key":"1502_CR36","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1212\/WNL.47.1.83","volume":"47","author":"GB Young","year":"1996","unstructured":"Young GB, Jordan KG, Doig GS. An assessment of nonconvulsive seizures in the intensive care unit using continuous EEG monitoring: an investigation of variables associated with mortality. Neurology. 1996;47(1):83\u20139.","journal-title":"Neurology"},{"issue":"3","key":"1502_CR37","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0920-1211(97)00071-5","volume":"29","author":"EJ Waterhouse","year":"1998","unstructured":"Waterhouse EJ, Vaughan JK, Barnes TY, Boggs JG, Towne AR, Kopec-Garnett L, et al. Synergistic effect of status epilepticus and ischemic brain injury on mortality. Epilepsy Res. 1998;29(3):175\u201383.","journal-title":"Epilepsy Res."},{"issue":"4","key":"1502_CR38","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1212\/WNL.52.4.746","volume":"52","author":"CM DeGiorgio","year":"1999","unstructured":"DeGiorgio CM, Heck CN, Rabinowicz AL, Gott PS, Smith T, Correale J. Serum neuron-specific enolase in the major subtypes of status epilepticus. Neurology. 1999;52(4):746\u20139.","journal-title":"Neurology"},{"issue":"9","key":"1502_CR39","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1212\/01.WNL.0000063316.47591.B4","volume":"60","author":"PM Vespa","year":"2003","unstructured":"Vespa PM, O\u2019Phelan K, Shah M, Mirabelli J, Starkman S, Kidwell C, et al. Acute seizures after intracerebral hemorrhage: a factor in progressive midline shift and outcome. Neurology. 2003;60(9):1441\u20136.","journal-title":"Neurology"},{"issue":"12","key":"1502_CR40","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1097\/01.CCM.0000295667.66853.BC","volume":"35","author":"PM Vespa","year":"2007","unstructured":"Vespa PM, Miller C, McArthur D, Eliseo M, Etchepare M, Hirt D, et al. Nonconvulsive electrographic seizures after traumatic brain injury result in a delayed, prolonged increase in intracranial pressure and metabolic crisis. Crit Care Med. 2007;35(12):2830\u20136.","journal-title":"Crit Care Med."},{"issue":"9","key":"1502_CR41","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1212\/WNL.0b013e3181f07334","volume":"75","author":"PM Vespa","year":"2010","unstructured":"Vespa PM, McArthur DL, Xu Y, Eliseo M, Etchepare M, Dinov I, et al. Nonconvulsive seizures after traumatic brain injury are associated with hippocampal atrophy. Neurology. 2010;75(9):792\u20138.","journal-title":"Neurology"},{"issue":"4","key":"1502_CR42","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1212\/WNL.0b013e31829c5cfe","volume":"81","author":"NS Abend","year":"2013","unstructured":"Abend NS, Arndt DH, Carpenter JL, Chapman KE, Cornett KM, Gallentine WB, et al. Electrographic seizures in pediatric ICU patients: cohort study of risk factors and mortality. Neurology. 2013;81(4):383\u201391.","journal-title":"Neurology"},{"issue":"Pt 5","key":"1502_CR43","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1093\/brain\/awu042","volume":"137","author":"ET Payne","year":"2014","unstructured":"Payne ET, Zhao XY, Frndova H, McBain K, Sharma R, Hutchison JS, et al. Seizure burden is independently associated with short term outcome in critically ill children. Brain. 2014;137(Pt 5):1429\u201338.","journal-title":"Brain"},{"issue":"5","key":"1502_CR44","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1212\/WNL.0000000000000082","volume":"82","author":"KL Wagenman","year":"2014","unstructured":"Wagenman KL, Blake TP, Sanchez SM, Schultheis MT, Radcliffe J, Berg RA, et al. Electrographic status epilepticus and long-term outcome in critically ill children. Neurology. 2014;82(5):396\u2013404.","journal-title":"Neurology"},{"issue":"3","key":"1502_CR45","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1212\/WNL.0000000000002281","volume":"86","author":"GM De Marchis","year":"2016","unstructured":"De Marchis GM, Pugin D, Meyers E, Velasquez A, Suwatcharangkoon S, Park S, et al. Seizure burden in subarachnoid hemorrhage associated with functional and cognitive outcome. Neurology. 2016;86(3):253\u201360.","journal-title":"Neurology"},{"issue":"4","key":"1502_CR46","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1002\/ana.24606","volume":"79","author":"P Vespa","year":"2016","unstructured":"Vespa P, Tubi M, Claassen J, Buitrago-Blanco M, McArthur D, Velazquez AG, et al. Metabolic crisis occurs with seizures and periodic discharges after brain trauma. Ann Neurol. 2016;79(4):579\u201390.","journal-title":"Ann Neurol."},{"issue":"3","key":"1502_CR47","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1001\/jamaneurol.2016.5325","volume":"74","author":"J Witsch","year":"2017","unstructured":"Witsch J, Frey HP, Schmidt JM, Velazquez A, Falo CM, Reznik M, et al. Electroencephalographic periodic discharges and frequency-dependent brain tissue hypoxia in acute brain injury. JAMA Neurol. 2017;74(3):301\u20139.","journal-title":"JAMA Neurol."},{"issue":"11","key":"1502_CR48","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1016\/j.clinph.2018.08.015","volume":"129","author":"SF Zafar","year":"2018","unstructured":"Zafar SF, Postma EN, Biswal S, Boyle EJ, Bechek S, O\u2019Connor K, et al. Effect of epileptiform abnormality burden on neurologic outcome and antiepileptic drug management after subarachnoid hemorrhage. Clin Neurophysiol. 2018;129(11):2219\u201327.","journal-title":"Clin Neurophysiol."},{"issue":"3","key":"1502_CR49","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s12028-020-00944-0","volume":"32","author":"M Tabaeizadeh","year":"2020","unstructured":"Tabaeizadeh M, Aboul Nour H, Shoukat M, Sun H, Jin J, Javed F, et al. Burden of epileptiform activity predicts discharge neurologic outcomes in severe acute ischemic stroke. Neurocrit Care. 2020;32(3):697\u2013706.","journal-title":"Neurocrit Care."},{"issue":"19","key":"1502_CR50","doi-asserted-by":"publisher","first-page":"7532","DOI":"10.1523\/JNEUROSCI.17-19-07532.1997","volume":"17","author":"J Kapur","year":"1997","unstructured":"Kapur J, Macdonald RL. Rapid seizure-induced reduction of benzodiazepine and Zn2+ sensitivity of hippocampal dentate granule cell GABAA receptors. J Neurosci. 1997;17(19):7532\u201340.","journal-title":"J Neurosci."},{"issue":"9","key":"1502_CR51","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1056\/NEJMoa002141","volume":"345","author":"BK Alldredge","year":"2001","unstructured":"Alldredge BK, Gelb AM, Isaacs SM, Corry MD, Allen F, Ulrich S, et al. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med. 2001;345(9):631\u20137.","journal-title":"N Engl J Med."},{"issue":"1","key":"1502_CR52","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1865-1380-6-6","volume":"6","author":"J Hillman","year":"2013","unstructured":"Hillman J, Lehtimaki K, Peltola J, Liimatainen S. Clinical significance of treatment delay in status epilepticus. Int J Emerg Med. 2013;6(1):6.","journal-title":"Int J Emerg Med."},{"issue":"5","key":"1502_CR53","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1111\/epi.13354","volume":"57","author":"RP Williams","year":"2016","unstructured":"Williams RP, Banwell B, Berg RA, Dlugos DJ, Donnelly M, Ichord R, et al. Impact of an ICU EEG monitoring pathway on timeliness of therapeutic intervention and electrographic seizure termination. Epilepsia. 2016;57(5):786\u201395.","journal-title":"Epilepsia"},{"issue":"3","key":"1502_CR54","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/epi.13653","volume":"58","author":"I Sanchez Fernandez","year":"2017","unstructured":"Sanchez Fernandez I, Sansevere AJ, Guerriero RM, Buraniqi E, Pearl PL, Tasker RC, et al. Time to electroencephalography is independently associated with outcome in critically ill neonates and children. Epilepsia. 2017;58(3):420\u20138.","journal-title":"Epilepsia"},{"issue":"10","key":"1502_CR55","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1212\/01.WNL.0000125184.88797.62","volume":"62","author":"J Claassen","year":"2004","unstructured":"Claassen J, Mayer SA, Kowalski RG, Emerson RG, Hirsch LJ. Detection of electrographic seizures with continuous EEG monitoring in critically ill patients. Neurology. 2004;62(10):1743\u20138.","journal-title":"Neurology"},{"issue":"8","key":"1502_CR56","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1016\/j.clinph.2006.11.312","volume":"118","author":"J Jirsch","year":"2007","unstructured":"Jirsch J, Hirsch LJ. Nonconvulsive seizures: developing a rational approach to the diagnosis and management in the critically ill population. Clin Neurophysiol. 2007;118(8):1660\u201370.","journal-title":"Clin Neurophysiol."},{"issue":"4","key":"1502_CR57","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/ane.12732","volume":"136","author":"MO Kinney","year":"2017","unstructured":"Kinney MO, Craig JJ, Kaplan PW. Hidden in plain sight: non-convulsive status epilepticus\u2014recognition and management. Acta Neurol Scand. 2017;136(4):280\u201392.","journal-title":"Acta Neurol Scand."},{"issue":"2","key":"1502_CR58","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/WNP.0000000000000166","volume":"32","author":"ST Herman","year":"2015","unstructured":"Herman ST, Abend NS, Bleck TP, Chapman KE, Drislane FW, Emerson RG, et al. Consensus statement on continuous EEG in critically ill adults and children, part I: indications. J Clin Neurophysiol. 2015;32(2):87\u201395.","journal-title":"J Clin Neurophysiol."},{"issue":"12","key":"1502_CR59","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1001\/jamaneurol.2017.2459","volume":"74","author":"AF Struck","year":"2017","unstructured":"Struck AF, Ustun B, Ruiz AR, Lee JW, LaRoche SM, Hirsch LJ, et al. Association of an electroencephalography-based risk score with seizure probability in hospitalized patients. JAMA Neurol. 2017;74(12):1419\u201324.","journal-title":"JAMA Neurol."},{"issue":"2","key":"1502_CR60","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/ana.24985","volume":"82","author":"AF Struck","year":"2017","unstructured":"Struck AF, Osman G, Rampal N, Biswal S, Legros B, Hirsch LJ, et al. Time-dependent risk of seizures in critically ill patients on continuous electroencephalogram. Ann Neurol. 2017;82(2):177\u201385.","journal-title":"Ann Neurol."},{"issue":"4","key":"1502_CR61","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1001\/jamaneurol.2019.4656","volume":"77","author":"AF Struck","year":"2020","unstructured":"Struck AF, Tabaeizadeh M, Schmitt SE, Ruiz AR, Swisher CB, Subramaniam T, et al. Assessment of the validity of the 2HELPS2B score for inpatient seizure risk prediction. JAMA Neurol. 2020;77(4):500\u20137.","journal-title":"JAMA Neurol."},{"issue":"1","key":"1502_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/WNP.0b013e3182784729","volume":"30","author":"LJ Hirsch","year":"2013","unstructured":"Hirsch LJ, LaRoche SM, Gaspard N, Gerard E, Svoronos A, Herman ST, et al. American Clinical Neurophysiology Society\u2019s standardized critical care EEG terminology: 2012 version. J Clin Neurophysiol. 2013;30(1):1\u201327.","journal-title":"J Clin Neurophysiol."},{"issue":"4","key":"1502_CR63","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1001\/jamaneurol.2013.6238","volume":"71","author":"JY Yoo","year":"2014","unstructured":"Yoo JY, Rampal N, Petroff OA, Hirsch LJ, Gaspard N. Brief potentially ictal rhythmic discharges in critically ill adults. JAMA Neurol. 2014;71(4):454\u201362.","journal-title":"JAMA Neurol."},{"issue":"9","key":"1502_CR64","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1111\/epi.12653","volume":"55","author":"N Gaspard","year":"2014","unstructured":"Gaspard N, Hirsch LJ, LaRoche SM, Hahn CD, Westover MB, Critical Care EEGMRC. Interrater agreement for Critical Care EEG Terminology. Epilepsia. 2014;55(9):1366\u201373.","journal-title":"Epilepsia"},{"issue":"2","key":"1502_CR65","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1001\/jamaneurol.2016.4990","volume":"74","author":"A Rodriguez Ruiz","year":"2017","unstructured":"Rodriguez Ruiz A, Vlachy J, Lee JW, Gilmore EJ, Ayer T, Haider HA, et al. Association of periodic and rhythmic electroencephalographic patterns with seizures in critically ill patients. JAMA Neurol. 2017;74(2):181\u20138.","journal-title":"JAMA Neurol."},{"issue":"Suppl 6","key":"1502_CR66","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/epi.12270","volume":"54","author":"S Beniczky","year":"2013","unstructured":"Beniczky S, Hirsch LJ, Kaplan PW, Pressler R, Bauer G, Aurlien H, et al. Unified EEG terminology and criteria for nonconvulsive status epilepticus. Epilepsia. 2013;54(Suppl 6):28\u20139.","journal-title":"Epilepsia"},{"issue":"10","key":"1502_CR67","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S1474-4422(16)30137-5","volume":"15","author":"M Leitinger","year":"2016","unstructured":"Leitinger M, Trinka E, Gardella E, Rohracher A, Kalss G, Qerama E, et al. Diagnostic accuracy of the Salzburg EEG criteria for non-convulsive status epilepticus: a retrospective study. Lancet Neurol. 2016;15(10):1054\u201362.","journal-title":"Lancet Neurol."},{"issue":"1","key":"1502_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/WNP.0000000000000806","volume":"38","author":"LJ Hirsch","year":"2021","unstructured":"Hirsch LJ, Fong MWK, Leitinger M, LaRoche SM, Beniczky S, Abend NS, et al. American Clinical Neurophysiology Society\u2019s standardized critical care EEG terminology: 2021 version. J Clin Neurophysiol. 2021;38(1):1\u201329.","journal-title":"J Clin Neurophysiol."},{"issue":"3","key":"1502_CR69","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s12028-020-00939-x","volume":"33","author":"EW Moffet","year":"2020","unstructured":"Moffet EW, Subramaniam T, Hirsch LJ, Gilmore EJ, Lee JW, Rodriguez-Ruiz AA, et al. Validation of the 2HELPS2B seizure risk score in acute brain injury patients. Neurocrit Care. 2020;33(3):701\u20137.","journal-title":"Neurocrit Care."},{"issue":"4","key":"1502_CR70","doi-asserted-by":"publisher","first-page":"e366","DOI":"10.1097\/CCM.0000000000003641","volume":"47","author":"C Limotai","year":"2019","unstructured":"Limotai C, Ingsathit A, Thadanipon K, McEvoy M, Attia J, Thakkinstian A. How and whom to monitor for seizures in an ICU: a systematic review and meta-analysis. Crit Care Med. 2019;47(4):e366\u201373.","journal-title":"Crit Care Med."},{"issue":"10","key":"1502_CR71","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1001\/jamaneurol.2020.2264","volume":"77","author":"AO Rossetti","year":"2020","unstructured":"Rossetti AO, Schindler K, Sutter R, Ruegg S, Zubler F, Novy J, et al. Continuous vs routine electroencephalogram in critically ill adults with altered consciousness and no recent seizure: a multicenter randomized clinical trial. JAMA Neurol. 2020;77(10):1225\u201332.","journal-title":"JAMA Neurol."},{"issue":"1","key":"1502_CR72","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1212\/WNL.0000000000006689","volume":"92","author":"CE Hill","year":"2019","unstructured":"Hill CE, Blank LJ, Thibault D, Davis KA, Dahodwala N, Litt B, et al. Continuous EEG is associated with favorable hospitalization outcomes for critically ill patients. Neurology. 2019;92(1):e9\u201318.","journal-title":"Neurology"},{"issue":"23","key":"1502_CR73","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1212\/01.wnl.0000436948.93399.2a","volume":"81","author":"JP Ney","year":"2013","unstructured":"Ney JP, van der Goes DN, Nuwer MR, Nelson L, Eccher MA. Continuous and routine EEG in intensive care: utilization and outcomes, United States 2005\u20132009. Neurology. 2013;81(23):2002\u20138.","journal-title":"Neurology"},{"issue":"6","key":"1502_CR74","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1002\/ana.25249","volume":"83","author":"AM Husain","year":"2018","unstructured":"Husain AM, Lee JW, Kolls BJ, Hirsch LJ, Halford JJ, Gupta PK, et al. Randomized trial of lacosamide versus fosphenytoin for nonconvulsive seizures. Ann Neurol. 2018;83(6):1174\u201385.","journal-title":"Ann Neurol."},{"issue":"22","key":"1502_CR75","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1056\/NEJMoa1905795","volume":"381","author":"J Kapur","year":"2019","unstructured":"Kapur J, Elm J, Chamberlain JM, Barsan W, Cloyd J, Lowenstein D, et al. Randomized trial of three anticonvulsant medications for status epilepticus. N Engl J Med. 2019;381(22):2103\u201313.","journal-title":"N Engl J Med."},{"issue":"10231","key":"1502_CR76","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/S0140-6736(20)30611-5","volume":"395","author":"JM Chamberlain","year":"2020","unstructured":"Chamberlain JM, Kapur J, Shinnar S, Elm J, Holsti M, Babcock L, et al. Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial. Lancet. 2020;395(10231):1217\u201324.","journal-title":"Lancet"},{"issue":"10186","key":"1502_CR77","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1016\/S0140-6736(19)30722-6","volume":"393","author":"SR Dalziel","year":"2019","unstructured":"Dalziel SR, Borland ML, Furyk J, Bonisch M, Neutze J, Donath S, et al. Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicentre, randomised controlled trial. Lancet. 2019;393(10186):2135\u201345.","journal-title":"Lancet"},{"issue":"10186","key":"1502_CR78","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1016\/S0140-6736(19)30724-X","volume":"393","author":"MD Lyttle","year":"2019","unstructured":"Lyttle MD, Rainford NEA, Gamble C, Messahel S, Humphreys A, Hickey H, et al. Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial. Lancet. 2019;393(10186):2125\u201334.","journal-title":"Lancet"},{"issue":"8","key":"1502_CR79","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1111\/epi.16094","volume":"60","author":"E Santamarina","year":"2019","unstructured":"Santamarina E, Parejo Carbonell B, Sala J, Guti\u00e9rrez-Viedma \u00c1, Mir\u00f3 J, Asensio M, et al. Use of intravenous brivaracetam in status epilepticus: a multicenter registry. Epilepsia. 2019;60(8):1593\u2013601.","journal-title":"Epilepsia"},{"issue":"7","key":"1502_CR80","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s40261-015-0295-5","volume":"35","author":"EY Moreno Morales","year":"2015","unstructured":"Moreno Morales EY, Fernandez Peleteiro M, Bondy Pe\u00f1a EC, Dom\u00ednguez Lorenzo JM, Pardellas Santiago E, Fern\u00e1ndez A. Observational study of intravenous lacosamide in patients with convulsive versus non-convulsive status epilepticus. Clin Drug Investig. 2015;35(7):463\u20139.","journal-title":"Clin Drug Investig."},{"issue":"10","key":"1502_CR81","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.seizure.2013.07.011","volume":"22","author":"V Belcastro","year":"2013","unstructured":"Belcastro V, Vidale S, Pierguidi L, Sironi L, Tancredi L, Striano P, et al. Intravenous lacosamide as treatment option in post-stroke non convulsive status epilepticus in the elderly: a proof-of-concept, observational study. Seizure. 2013;22(10):905\u20137.","journal-title":"Seizure."},{"issue":"4","key":"1502_CR82","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/ane.13061","volume":"139","author":"A Strzelczyk","year":"2019","unstructured":"Strzelczyk A, Knake S, Kalviainen R, Santamarina E, Toledo M, Willig S, et al. Perampanel for treatment of status epilepticus in Austria, Finland, Germany, and Spain. Acta Neurol Scand. 2019;139(4):369\u201376.","journal-title":"Acta Neurol Scand."},{"issue":"Suppl 2","key":"1502_CR83","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/epi.14494","volume":"59","author":"A Rohracher","year":"2018","unstructured":"Rohracher A, Kalss G, Neuray C, H\u00f6fler J, Dobesberger J, Kuchukhidze G, et al. Perampanel in patients with refractory and super-refractory status epilepticus in a neurological intensive care unit: a single-center audit of 30 patients. Epilepsia. 2018;59(Suppl 2):234\u201342.","journal-title":"Epilepsia"},{"issue":"12","key":"1502_CR84","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1111\/epi.16382","volume":"60","author":"A Fechner","year":"2019","unstructured":"Fechner A, Hubert K, Jahnke K, Knake S, Konczalla J, Menzler K, et al. Treatment of refractory and superrefractory status epilepticus with topiramate: a cohort study of 106 patients and a review of the literature. Epilepsia. 2019;60(12):2448\u201358.","journal-title":"Epilepsia"},{"key":"1502_CR85","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.seizure.2016.03.003","volume":"38","author":"D Mad\u017ear","year":"2016","unstructured":"Mad\u017ear D, Kuramatsu JB, Gerner ST, Huttner HB. Assessing the value of topiramate in refractory status epilepticus. Seizure. 2016;38:7\u201310.","journal-title":"Seizure."},{"issue":"2","key":"1502_CR86","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.seizure.2012.11.004","volume":"22","author":"CB Swisher","year":"2013","unstructured":"Swisher CB, Doreswamy M, Husain AM. Use of pregabalin for nonconvulsive seizures and nonconvulsive status epilepticus. Seizure. 2013;22(2):116\u20138.","journal-title":"Seizure."},{"issue":"1","key":"1502_CR87","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12883-016-0724-y","volume":"16","author":"D Mad\u017ear","year":"2016","unstructured":"Mad\u017ear D, Geyer A, Knappe RU, Gollwitzer S, Kuramatsu JB, Gerner ST, et al. Effects of clobazam for treatment of refractory status epilepticus. BMC Neurol. 2016;16(1):202.","journal-title":"BMC Neurol."},{"issue":"6","key":"1502_CR88","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.1111\/epi.13013","volume":"56","author":"S Sivakumar","year":"2015","unstructured":"Sivakumar S, Ibrahim M, Parker D Jr, Norris G, Shah A, Mohamed W. Clobazam: an effective add-on therapy in refractory status epilepticus. Epilepsia. 2015;56(6):e83\u20139.","journal-title":"Epilepsia"},{"issue":"5","key":"1502_CR89","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/ane.12414","volume":"132","author":"GD Rudd","year":"2015","unstructured":"Rudd GD, Haverkamp W, Mason JW, Wenger T, Jay G, Hebert D, et al. Lacosamide cardiac safety: clinical trials in patients with partial-onset seizures. Acta Neurol Scand. 2015;132(5):355\u201363.","journal-title":"Acta Neurol Scand."},{"key":"1502_CR90","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.eplepsyres.2018.12.001","volume":"149","author":"I Aicua-Rapun","year":"2019","unstructured":"Aicua-Rapun I, Andr\u00e9 P, Rossetti AO, Decosterd LA, Buclin T, Novy J. Intravenous brivaracetam in status epilepticus: correlation between loading dose, plasma levels and clinical response. Epilepsy Res. 2019;149:88\u201391.","journal-title":"Epilepsy Res."},{"issue":"2","key":"1502_CR91","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/epi4.12383","volume":"5","author":"N Orlandi","year":"2020","unstructured":"Orlandi N, Giovannini G, Rossi J, Cioclu MC, Meletti S. Clinical outcomes and treatments effectiveness in status epilepticus resolved by antiepileptic drugs: a five-year observational study. Epilepsia Open. 2020;5(2):166\u201375.","journal-title":"Epilepsia Open."},{"key":"1502_CR92","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.seizure.2020.03.002","volume":"78","author":"L Li","year":"2020","unstructured":"Li L, Zhang Y, Jia L, Jia D, Faramand A, Chong W, et al. Levetiracetam versus phenytoin for the treatment of established status epilepticus: A systematic review and meta-analysis of randomized controlled trials. Seizure. 2020;78:43\u20138.","journal-title":"Seizure."},{"key":"1502_CR93","doi-asserted-by":"publisher","first-page":"107286","DOI":"10.1016\/j.yebeh.2020.107286","volume":"111","author":"JM DeMott","year":"2020","unstructured":"DeMott JM, Slocum GW, Gottlieb M, Peksa GD. Levetiracetam vs. phenytoin as 2nd-line treatment for status epilepticus: A systematic review and meta-analysis. Epilepsy Behav. 2020;111:107286.","journal-title":"Epilepsy Behav."},{"key":"1502_CR94","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1007\/s40263-020-00770-0","volume":"34","author":"T Xue","year":"2020","unstructured":"Xue T, Wei L, Shen X, Wang Z, Chen Z, Wang Z. Levetiracetam versus phenytoin for the pharmacotherapy of benzodiazepine-refractory status epilepticus: a systematic review and meta-analysis of randomized controlled trials. CNS Drugs. 2020;34:1205\u201315.","journal-title":"CNS Drugs"},{"issue":"Pt A","key":"1502_CR95","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.yebeh.2017.03.018","volume":"71","author":"J Redecker","year":"2017","unstructured":"Redecker J, Wittstock M, R\u00f6sche J. The efficacy of different kinds of intravenously applied antiepileptic drugs in the treatment of status epilepticus. How can it be determined? Epilepsy Behav. 2017;71(Pt A):35\u20138.","journal-title":"Epilepsy Behav."},{"key":"1502_CR96","doi-asserted-by":"crossref","unstructured":"Foreman B, Hirsch LJ. Epilepsy emergencies: diagnosis and management. Neurol Clin. 2012;30(1):11\u201341, vii.","DOI":"10.1016\/j.ncl.2011.09.005"},{"issue":"3 Epilepsy","key":"1502_CR97","first-page":"767","volume":"19","author":"LJ Hirsch","year":"2013","unstructured":"Hirsch LJ, Gaspard N. Status epilepticus. Continuum (Minneap Minn). 2013;19(3 Epilepsy):767\u201394.","journal-title":"Continuum (Minneap Minn)."},{"issue":"4","key":"1502_CR98","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.spen.2014.12.006","volume":"21","author":"NS Abend","year":"2014","unstructured":"Abend NS, Bearden D, Helbig I, McGuire J, Narula S, Panzer JA, et al. Status epilepticus and refractory status epilepticus management. Semin Pediatr Neurol. 2014;21(4):263\u201374.","journal-title":"Semin Pediatr Neurol."},{"issue":"6","key":"1502_CR99","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/S1474-4422(15)00042-3","volume":"14","author":"JP Betjemann","year":"2015","unstructured":"Betjemann JP, Lowenstein DH. Status epilepticus in adults. Lancet Neurol. 2015;14(6):615\u201324.","journal-title":"Lancet Neurol."},{"issue":"13","key":"1502_CR100","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1007\/s40265-015-0454-2","volume":"75","author":"E Trinka","year":"2015","unstructured":"Trinka E, Hofler J, Leitinger M, Brigo F. Pharmacotherapy for status epilepticus. Drugs. 2015;75(13):1499\u2013521.","journal-title":"Drugs"},{"issue":"3","key":"1502_CR101","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11940-016-0394-5","volume":"18","author":"EH Grover","year":"2016","unstructured":"Grover EH, Nazzal Y, Hirsch LJ. Treatment of convulsive status epilepticus. Curr Treat Options Neurol. 2016;18(3):11.","journal-title":"Curr Treat Options Neurol."},{"issue":"5","key":"1502_CR102","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3390\/jcm5050049","volume":"5","author":"JJ Falco-Walter","year":"2016","unstructured":"Falco-Walter JJ, Bleck T. Treatment of established status epilepticus. J Clin Med. 2016;5(5):49:1\u20138.","journal-title":"J Clin Med."},{"issue":"3","key":"1502_CR103","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s40265-017-0859-1","volume":"78","author":"M Holtkamp","year":"2018","unstructured":"Holtkamp M. Pharmacotherapy for refractory and super-refractory status epilepticus in adults. Drugs. 2018;78(3):307\u201326.","journal-title":"Drugs"},{"issue":"3","key":"1502_CR104","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/phar.2229","volume":"39","author":"S Farrokh","year":"2019","unstructured":"Farrokh S, Bon J, Erdman M, Tesoro E. Use of newer anticonvulsants for the treatment of status epilepticus. Pharmacotherapy. 2019;39(3):297\u2013316.","journal-title":"Pharmacotherapy"},{"issue":"1","key":"1502_CR105","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s40263-019-00690-8","volume":"34","author":"A Singh","year":"2020","unstructured":"Singh A, Stredny CM, Loddenkemper T. Pharmacotherapy for pediatric convulsive status epilepticus. CNS Drugs. 2020;34(1):47\u201363.","journal-title":"CNS Drugs"},{"issue":"3","key":"1502_CR106","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1007\/s11940-015-0340-y","volume":"17","author":"M Wasim","year":"2015","unstructured":"Wasim M, Husain AM. Nonconvulsive seizure control in the intensive care unit. Curr Treat Options Neurol. 2015;17(3):340.","journal-title":"Curr Treat Options Neurol."},{"issue":"2","key":"1502_CR107","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s12028-012-9790-1","volume":"18","author":"JJ Riviello Jr","year":"2013","unstructured":"Riviello JJ Jr, Claassen J, LaRoche SM, Sperling MR, Alldredge B, Bleck TP, et al. Treatment of status epilepticus: an international survey of experts. Neurocrit Care. 2013;18(2):193\u2013200.","journal-title":"Neurocrit Care."},{"issue":"3","key":"1502_CR108","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/j.1468-1331.2009.02917.x","volume":"17","author":"H Meierkord","year":"2010","unstructured":"Meierkord H, Boon P, Engelsen B, Gocke K, Shorvon S, Tinuper P, et al. EFNS guideline on the management of status epilepticus in adults. Eur J Neurol. 2010;17(3):348\u201355.","journal-title":"Eur J Neurol."},{"issue":"1","key":"1502_CR109","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12028-012-9695-z","volume":"17","author":"GM Brophy","year":"2012","unstructured":"Brophy GM, Bell R, Claassen J, Alldredge B, Bleck TP, Glauser T, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care. 2012;17(1):3\u201323.","journal-title":"Neurocrit Care."},{"issue":"1","key":"1502_CR110","doi-asserted-by":"publisher","first-page":"48","DOI":"10.5698\/1535-7597-16.1.48","volume":"16","author":"T Glauser","year":"2016","unstructured":"Glauser T, Shinnar S, Gloss D, Alldredge B, Arya R, Bainbridge J, et al. Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline Committee of the American Epilepsy Society. Epilepsy Curr. 2016;16(1):48\u201361.","journal-title":"Epilepsy Curr."},{"issue":"3","key":"1502_CR111","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1007\/s12028-010-9337-2","volume":"12","author":"NS Abend","year":"2010","unstructured":"Abend NS, Dlugos DJ, Hahn CD, Hirsch LJ, Herman ST. Use of EEG monitoring and management of non-convulsive seizures in critically ill patients: a survey of neurologists. Neurocrit Care. 2010;12(3):382\u20139.","journal-title":"Neurocrit Care."},{"key":"1502_CR112","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.cnp.2019.07.001","volume":"4","author":"AO Rossetti","year":"2019","unstructured":"Rossetti AO, Hirsch LJ, Drislane FW. Nonconvulsive seizures and nonconvulsive status epilepticus in the neuro ICU should or should not be treated aggressively: a debate. Clin Neurophysiol Pract. 2019;4:170\u20137.","journal-title":"Clin Neurophysiol Pract."},{"issue":"7","key":"1502_CR113","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nrn1430","volume":"5","author":"MA Rogawski","year":"2004","unstructured":"Rogawski MA, Loscher W. The neurobiology of antiepileptic drugs. Nat Rev Neurosci. 2004;5(7):553\u201364.","journal-title":"Nat Rev Neurosci."},{"key":"1502_CR114","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0074-7742(06)81006-8","volume":"81","author":"HS White","year":"2007","unstructured":"White HS, Smith MD, Wilcox KS. Mechanisms of action of antiepileptic drugs. Int Rev Neurobiol. 2007;81:85\u2013110.","journal-title":"Int Rev Neurobiol."},{"issue":"1","key":"1502_CR115","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1080\/14656566.2018.1541349","volume":"20","author":"A Morano","year":"2019","unstructured":"Morano A, Iannone L, Palleria C, Fanella M, Giallonardo AT, De Sarro G, et al. Pharmacology of new and developing intravenous therapies for the management of seizures and epilepsy. Expert Opin Pharmacother. 2019;20(1):25\u201339.","journal-title":"Expert Opin Pharmacother."},{"issue":"2","key":"1502_CR116","first-page":"508","volume":"25","author":"BW Abou-Khalil","year":"2019","unstructured":"Abou-Khalil BW. Update on antiepileptic drugs 2019. Continuum (Minneap Minn). 2019;25(2):508\u201336.","journal-title":"Continuum (Minneap Minn)."},{"issue":"18","key":"1502_CR117","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1212\/WNL.0000000000001940","volume":"85","author":"N Gaspard","year":"2015","unstructured":"Gaspard N, Foreman BP, Alvarez V, Cabrera Kang C, Probasco JC, Jongeling AC, et al. New-onset refractory status epilepticus: etiology, clinical features, and outcome. Neurology. 2015;85(18):1604\u201313.","journal-title":"Neurology"},{"issue":"4","key":"1502_CR118","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1111\/epi.14016","volume":"59","author":"LJ Hirsch","year":"2018","unstructured":"Hirsch LJ, Gaspard N, van Baalen A, Nabbout R, Demeret S, Loddenkemper T, et al. Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions. Epilepsia. 2018;59(4):739\u201344.","journal-title":"Epilepsia"},{"issue":"4","key":"1502_CR119","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1111\/epi.14022","volume":"59","author":"N Gaspard","year":"2018","unstructured":"Gaspard N, Hirsch LJ, Sculier C, Loddenkemper T, van Baalen A, Lancrenon J, et al. New-onset refractory status epilepticus (NORSE) and febrile infection-related epilepsy syndrome (FIRES): state of the art and perspectives. Epilepsia. 2018;59(4):745\u201352.","journal-title":"Epilepsia"},{"issue":"4","key":"1502_CR120","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1001\/jamaneurol.2017.4382","volume":"75","author":"M Gainza-Lein","year":"2018","unstructured":"Gainza-Lein M, Sanchez Fernandez I, Jackson M, Abend NS, Arya R, Brenton JN, et al. Association of time to treatment with short-term outcomes for pediatric patients with refractory convulsive status epilepticus. JAMA Neurol. 2018;75(4):410\u20138.","journal-title":"JAMA Neurol."},{"key":"1502_CR121","doi-asserted-by":"crossref","unstructured":"Vossler DG, Bainbridge JL, Boggs JG, Novotny EJ, Loddenkemper T, Faught E, et al. Treatment of Refractory Convulsive Status Epilepticus: A Comprehensive Review by the American Epilepsy Society Treatments Committee. Epilepsy Curr. 2020;20(5):245\u2013264","DOI":"10.1177\/1535759720928269"},{"issue":"8","key":"1502_CR122","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1212\/WNL.0000000000000009","volume":"82","author":"R Sutter","year":"2014","unstructured":"Sutter R, Marsch S, Fuhr P, Kaplan PW, Ruegg S. Anesthetic drugs in status epilepticus: risk or rescue? A 6-year cohort study. Neurology. 2014;82(8):656\u201364.","journal-title":"Neurology"},{"issue":"6","key":"1502_CR123","doi-asserted-by":"publisher","first-page":"313","DOI":"10.5698\/1535-7511-15.6.313","volume":"15","author":"LJ Hirsch","year":"2015","unstructured":"Hirsch LJ. Finding the lesser of two evils: treating refractory status epilepticus. Epilepsy Curr. 2015;15(6):313\u20136.","journal-title":"Epilepsy Curr."},{"issue":"5","key":"1502_CR124","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1097\/CCM.0000000000000881","volume":"43","author":"NA Marchi","year":"2015","unstructured":"Marchi NA, Novy J, Faouzi M, Stahli C, Burnand B, Rossetti AO. Status epilepticus: impact of therapeutic coma on outcome. Crit Care Med. 2015;43(5):1003\u20139.","journal-title":"Crit Care Med."},{"issue":"16","key":"1502_CR125","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1212\/WNL.0000000000003224","volume":"87","author":"V Alvarez","year":"2016","unstructured":"Alvarez V, Lee JW, Westover MB, Drislane FW, Novy J, Faouzi M, et al. Therapeutic coma for status epilepticus: differing practices in a prospective multicenter study. Neurology. 2016;87(16):1650\u20139.","journal-title":"Neurology"},{"issue":"5","key":"1502_CR126","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1111\/epi.14706","volume":"60","author":"WG Muhlhofer","year":"2019","unstructured":"Muhlhofer WG, Layfield S, Lowenstein D, Lin CP, Johnson RD, Saini S, et al. Duration of therapeutic coma and outcome of refractory status epilepticus. Epilepsia. 2019;60(5):921\u201334.","journal-title":"Epilepsia"},{"issue":"6","key":"1502_CR127","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/ane.13302","volume":"142","author":"E Caronna","year":"2020","unstructured":"Caronna E, Vilaseca A, Maria Gracia Gozalo R, Sanchez Corral A, Santafe M, Sueiras M, et al. Long-term prognosis related to deep sedation in refractory status Epilepticus. Acta Neurol Scand. 2020;142(6):555\u201362.","journal-title":"Acta Neurol Scand."},{"key":"1502_CR128","unstructured":"Yale New Haven Hospital Treatment Algorithm for Generalized Convulsive Status Epilepticus in adults: NORSE Institute.; 2020. http:\/\/www.norseinstitute.org\/definitions. Accessed 28 Feb 2021."}],"container-title":["Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-021-01502-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40265-021-01502-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-021-01502-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T02:07:05Z","timestamp":1675130825000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40265-021-01502-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,8]]},"references-count":128,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["1502"],"URL":"https:\/\/doi.org\/10.1007\/s40265-021-01502-4","relation":{},"ISSN":["0012-6667","1179-1950"],"issn-type":[{"value":"0012-6667","type":"print"},{"value":"1179-1950","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,8]]},"assertion":[{"value":"13 March 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Dr. Bravo and Dr. Vaddiparti have no conflicts of interest\/competing interests. Dr. Hirsch has received consultation fees for advising from Accure, Aquestive, Ceribell, Marinus, Medtronic, Neuropace and UCB; royalties from Wolters-Kluwer for authoring chapters for UpToDate-Neurology, and from Wiley for co-authoring the book \u201cAtlas of EEG in Critical Care\u201d, by Hirsch and Brenner; and honoraria for speaking from Neuropace and Natus.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest\/competing interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Dr. PB contributed to the draft of the entire manuscript and design of all figures; Dr. AV contributed to the draft of Sect. 4.1 (Evidence on pharmacotherapy for NCSs and NCSE) including Table 1 and design of Fig. 3; Dr. LJH contributed to the draft and revision of the entire manuscript as well as design of all figures and tables. All authors have reviewed and read the final version of this manuscript.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}